Telix gets FDA Fast Track for BiPASS pre-biopsy prostate imaging programSep 29Regulatory milestoneTelix Pharmaceuticals Ltd
Telix Pharmaceuticals to merge with ITM Isotope Technologies Munich in radiopharma dealSep 21M&ATelix Pharmaceuticals Ltd
FDA approves Telix's Pixclara for glioma imagingSep 14Regulatory decisionfloretyrosine f 18Telix Pharmaceuticals Ltd
Telix finishes enrollment in Phase 3 BiPASS trial, aligns with FDA on NDA pathSep 1Clinical readoutTelix Pharmaceuticals Ltd
Telix reports 22% H1 2026 revenue growth, guides to upper end of FY targetsAug 19Clinical readoutTelix Pharmaceuticals Ltd
Telix and FDA align on ProstACT Global Phase 3 protocol, IND amendment pendingJul 2Clinical readoutTelix Pharmaceuticals Ltd
Sign in